Speakers: Amy S. Lay, MD and M. Petrea Cober, PharmD, BCNSP, BCPPS, FASPENTarget Audience: Pharmacists
Fee: $10 (or $70 for all 10 courses). To purchase the bundle, click here.
Expiration Date: September 19, 2024
For C4 2022 participants who registered for the live program, please use the access code provided to you by email.
CE: 1.0 contact hours (0.1 CEUs)
Purpose: To educate pharmacists on the current possible treatments for a patent ductus arteriosus (PDA) closure, when it is clinically applicable to close the PDA and what happens if medical treatment fails.
To educate pharmacists on the current evidence for neonatal refeeding syndrome in very-low birth weight premature infants, as well as prevention and treatment strategies for management.
To educate pharmacists on recent ASPEN guidelines involving the administration of parenteral nutrition and newer lipid injectable emulsions in neonatal/pediatric patients.
Click here for the full description.
UAN: 0016-0000-22-051-H01-P